Karayel Emre, Ocak Meltem, Birteksöz Tan A Seher
İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Turkey.
İstanbul University, Institute of Graduate Studies in Health Sciences, İstanbul, Turkey.
Mol Imaging Radionucl Ther. 2023 Feb 23;32(1):28-34. doi: 10.4274/mirt.galenos.2022.77598.
The aim of this study is to evaluation of Tc-99m-hexamethylpropyleneamineoxime (HMPAO)-labeled leukocytes in terms of radiochemical, biochemical, and microbiological quality controls and to examine the effect of leukocyte numbers of the blood obtained from patients and the medications currently used by the patients on the radiochemical yields of Tc-99m-HMPAO-labeled leukocytes, and imaging quality was evaluated.
Thirty paients were included in our study who applied to Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Nuclear Medicine for Tc-99m-HMPAO-labeled leukocyte scintigraphy. Devices and chemicals used in the preparation of Tc-99m-HMPAO-labeled laukocytes were compared with other nuclear medicine clinics. Tc-99m-HMPAO-labeled leukocytes were evaluated in terms of radiochemical, biochemical, and microbiological quality controls. The effect of leukocyte numbers of the blood obtained from patients and the medications currently used by the patients on the radiochemical yields of Tc-99m-HMPAO-labeled leukocytes and imaging quality was evaluated.
The pH range of Tc-99m-HMPAO was 6-8 and the radiochemical purity was 90±2.04% (n=30), the radiochemical yield of Tc-99m-HMPAO-labeled leukocytes was 51±2.18% (n=30), the radiolabeling yield of Tc-99m-HMPAO-labeled leukocyte increased as the amount of white blood cell in the blood increased and whether the patients used any antibiotic, blood thinners, insulin and blood pressure medications did not affect the radiolabeling yield of Tc-99m-HMPAO-labeled leukocytes. The number of erythrocytes were removed at a rate of >99% in LPR by starch solution (6% HES; in the hemocytometric examination of Tc-99m-HMPAO-labeled leukocytes performed zeroth and 4th h, living/dead cell ratio was found 97.5% and the product was sterile.
Tc-99m-HMPAO was labeled with leukocytes successfully, and Tc-99m-HMPAO-labeled leukocytes was safely injected to the patients as sterile without loss of vitality and aggregation.
本研究旨在从放射化学、生物化学和微生物学质量控制方面评估锝-99m-六甲基丙烯胺肟(HMPAO)标记的白细胞,并研究患者所获血液中的白细胞数量以及患者目前使用的药物对锝-99m-HMPAO标记白细胞的放射化学产率的影响,同时对成像质量进行评估。
本研究纳入了30例因锝-99m-HMPAO标记白细胞闪烁显像而前往伊斯坦布尔大学-塞拉哈帕夏医学院核医学科就诊的患者。将制备锝-99m-HMPAO标记白细胞所使用的设备和化学试剂与其他核医学科室进行了比较。从放射化学、生物化学和微生物学质量控制方面对锝-99m-HMPAO标记的白细胞进行了评估。研究了患者所获血液中的白细胞数量以及患者目前使用的药物对锝-99m-HMPAO标记白细胞的放射化学产率和成像质量的影响。
锝-99m-HMPAO的pH范围为6至8,放射化学纯度为90±2.04%(n = 30),锝-99m-HMPAO标记白细胞的放射化学产率为51±2.18%(n = 30),随着血液中白细胞数量的增加,锝-99m-HMPAO标记白细胞的放射性标记产率增加,且患者是否使用任何抗生素、血液稀释剂、胰岛素和血压药物均不影响锝-99m-HMPAO标记白细胞的放射性标记产率。通过淀粉溶液(6%羟乙基淀粉;HES)在白细胞分离程序(LPR)中红细胞去除率>99%,在对锝-99m-HMPAO标记白细胞进行第0小时和第4小时血细胞计数检查时,活/死细胞比率为97.5%,且产品无菌。
锝-99m-HMPAO成功标记白细胞,且锝-99m-HMPAO标记的白细胞作为无菌产品安全地注射给患者,无活力丧失和聚集现象。